Ghost Tree Capital, LLC Hedge Fund

CIK: 0001595851 · Show all filings

Period: Q2 2018 (← Previous) (Next →)

Filing Date: Aug 14, 2018

Total Value: $340M (100.0% shares, 0.0% debt)

Holdings (46)

— IMMUNOMEDICS INC 8.7%
Value $29.59M Shares 1,250,000 Share Price $23.67 Est. Cost/Share $8.35 Unrealized @ Report Date —
— MIRATI THERAPEUTICS INC 7.3%
Value $24.65M Shares 500,000 Share Price $49.30 Est. Cost/Share $33.00 Unrealized @ Report Date —
SRPT SAREPTA THERAPEUTICS INC 6.8%
Value $23.13M Shares 175,000 Share Price $132.18 * Est. Cost/Share $66.68 Unrealized @ Report Date +41.4%
PTCT PTC THERAPEUTICS INC 6.7%
Value $22.77M Shares 675,000 Share Price $33.73 * Est. Cost/Share $29.45 Unrealized @ Report Date +5.9%
ALNY ALNYLAM PHARMACEUTICALS INC 6.1%
Value $20.68M Shares 210,000 Share Price $98.49 Est. Cost/Share $99.19 Unrealized @ Report Date 0.0%
— BLUEBIRD BIO INC 4.9%
Value $16.48M Shares 105,000 Share Price $156.95 Est. Cost/Share $156.95 Unrealized @ Report Date —
ARGX ARGENX SE 3.7%
Value $12.43M Shares 150,000 Share Price $82.86 Est. Cost/Share $21.52 Unrealized @ Report Date —
ASND ASCENDIS PHARMA A S 3.4%
Value $11.64M Shares 175,000 Share Price $66.52 Est. Cost/Share $42.91 Unrealized @ Report Date —
— GLOBAL BLOOD THERAPEUTICS IN 3.2%
Value $10.94M Shares 242,000 Share Price $45.20 Est. Cost/Share $45.20 Unrealized @ Report Date —
— MERSANA THERAPEUTICS INC 3.2%
Value $10.72M Shares 600,000 Share Price $17.86 Est. Cost/Share $16.89 Unrealized @ Report Date —
ARWR ARROWHEAD PHARMACEUTICALS IN 2.8%
Value $9.52M Shares 700,000 Share Price $13.60 * Est. Cost/Share $6.16 Unrealized @ Report Date +51.8%
— ASSEMBLY BIOSCIENCES INC 2.7%
Value $9.214M Shares 235,000 Share Price $39.21 Est. Cost/Share $45.55 Unrealized @ Report Date —
EXEL EXELIXIS INC 2.5%
Value $8.608M Shares 400,000 Share Price $21.52 * Est. Cost/Share $20.68 Unrealized @ Report Date 0.0%
ACAD ACADIA PHARMACEUTICALS INC 2.4%
Value $8.169M Shares 535,000 Share Price $15.27 * Est. Cost/Share $25.20 Unrealized @ Report Date -29.2%
— DICERNA PHARMACEUTICALS INC 2.4%
Value $8.085M Shares 660,000 Share Price $12.25 Est. Cost/Share $9.28 Unrealized @ Report Date —
— ADAMAS PHARMACEUTICALS INC 2.2%
Value $7.62M Shares 295,000 Share Price $25.83 Est. Cost/Share $23.90 Unrealized @ Report Date —
— KADMON HLDGS INC 2.2%
Value $7.581M Shares 1,900,000 Share Price $3.99 Est. Cost/Share $3.88 Unrealized @ Report Date —
— ENDOCYTE INC 2.0%
Value $6.9M Shares 500,000 Share Price $13.80 Est. Cost/Share $9.09 Unrealized @ Report Date —
RCKT ROCKET PHARMACEUTICALS INC 2.0%
Value $6.871M Shares 350,000 Share Price $19.63 * Est. Cost/Share $16.31 Unrealized @ Report Date +16.0%
MDGL MADRIGAL PHARMACEUTICALS INC 1.9%
Value $6.573M Shares 23,500 Share Price $279.70 * Est. Cost/Share $175.60 Unrealized @ Report Date 0.0%
— AVROBIO INC 1.9%
Value $6.569M Shares 230,000 Share Price $28.56 Est. Cost/Share $28.56 Unrealized @ Report Date —
— GLYCOMIMETICS INC 1.9%
Value $6.452M Shares 400,000 Share Price $16.13 Est. Cost/Share $16.19 Unrealized @ Report Date —
VRAYQ VIEWRAY INC 1.8%
Value $6.228M Shares 900,000 Share Price $6.92 * Est. Cost/Share $6.99 Unrealized @ Report Date +4.0%
— OBSEVA SA 1.8%
Value $6.056M Shares 400,000 Share Price $15.14 Est. Cost/Share $9.76 Unrealized @ Report Date —
— TRICIDA INC 1.6%
Value $5.562M Shares 186,019 Share Price $29.90 Est. Cost/Share $29.90 Unrealized @ Report Date —
— AUDENTES THERAPEUTICS INC 1.4%
Value $4.776M Shares 125,000 Share Price $38.21 Est. Cost/Share $38.21 Unrealized @ Report Date —
IOVA IOVANCE BIOTHERAPEUTICS INC 1.4%
Value $4.608M Shares 360,000 Share Price $12.80 * Est. Cost/Share $15.14 Unrealized @ Report Date -3.5%
KURA KURA ONCOLOGY INC 1.2%
Value $4.186M Shares 230,000 Share Price $18.20 * Est. Cost/Share $16.94 Unrealized @ Report Date 0.0%
— BIODELIVERY SCIENCES INTL IN 1.2%
Value $4.163M Shares 1,411,247 Share Price $2.95 Est. Cost/Share $2.95 Unrealized @ Report Date —
— CATALYST BIOSCIENCES INC 1.2%
Value $4.143M Shares 355,000 Share Price $11.67 Est. Cost/Share $25.80 Unrealized @ Report Date —
APLS APELLIS PHARMACEUTICALS INC 1.2%
Value $4.07M Shares 185,000 Share Price $22.00 * Est. Cost/Share $22.98 Unrealized @ Report Date 0.0%
— NEOS THERAPEUTICS INC 1.1%
Value $3.75M Shares 600,000 Share Price $6.25 Est. Cost/Share $7.80 Unrealized @ Report Date —
— LANNET INC 1.0%
Value $3.4M Shares 250,000 Share Price $13.60 Est. Cost/Share $16.05 Unrealized @ Report Date —
— GENOCEA BIOSCIENCES INC 0.9%
Value $3.016M Shares 3,525,000 Share Price $0.86 Est. Cost/Share $0.86 Unrealized @ Report Date —
— AVADEL PHARMACEUTICALS PLC 0.8%
Value $2.759M Shares 450,000 Share Price $6.13 Est. Cost/Share $7.29 Unrealized @ Report Date —
ANAB ANAPTYSBIO INC 0.3%
Value $1.115M Shares 15,700 Share Price $71.02 * Est. Cost/Share $100.41 Unrealized @ Report Date -16.5%
— ZAFGEN INC 0.3%
Value $1.046M Shares 102,263 Share Price $10.23 Est. Cost/Share $10.23 Unrealized @ Report Date —
— ACORDA THERAPEUTICS INC 0.3%
Value $947K Shares 33,000 Share Price $28.70 Est. Cost/Share $28.70 Unrealized @ Report Date —
PBYI PUMA BIOTECHNOLOGY INC 0.2%
Value $828K Shares 14,000 Share Price $59.14 * Est. Cost/Share $57.95 Unrealized @ Report Date 0.0%
— EDGE THERAPEUTICS INC 0.2%
Value $773K Shares 750,792 Share Price $1.03 Est. Cost/Share $1.03 Unrealized @ Report Date —
— MOTUS GI HLDGS INC 0.2%
Value $719K Shares 100,000 Share Price $7.19 Est. Cost/Share $4.48 Unrealized @ Report Date —
TGTX TG THERAPEUTICS INC 0.2%
Value $684K Shares 52,000 Share Price $13.15 * Est. Cost/Share $12.78 Unrealized @ Report Date +7.6%
— SPECTRUM PHARMACEUTICALS INC 0.2%
Value $608K Shares 29,000 Share Price $20.97 Est. Cost/Share $20.97 Unrealized @ Report Date —
XBI SPDR SERIES TRUST 0.2%
Value $525K Shares 5,000 Share Price $105.00 Est. Cost/Share — Unrealized @ Report Date —
— LANNET INC 0.2%
Value $520K Shares 2,000 Share Price $260.00 Est. Cost/Share $16.05 Unrealized @ Report Date —
— BIOHAVEN PHARMACTL HLDG CO L 0.0%
Value $122K Shares 2,000 Share Price $61.00 Est. Cost/Share $26.17 Unrealized @ Report Date —